Tranexamic Acid for severe endometriosis surgery
Phase 4
Recruiting
- Conditions
- EndometriosisReproductive Health and Childbirth - Other reproductive health and childbirth disorders
- Registration Number
- ACTRN12618001318279
- Lead Sponsor
- The Royal Women's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Suspected severe endometriosis (based on clinical or radiological evidence or findings at previous diagnostic laparoscopy)
Proposed laparoscopic surgery to treat endometriosis of > 2 hours
Planned surgery under level 6 gynaecological surgeons’ operating lists
Exclusion Criteria
Non consent
Non English speaking
Allergy or contraindication to tranexamic acid including: thrombophilia, previous/active thromboembolic disease, subarachnoid haemorrhage, malignancy or antithrombotic treatment
Hysterectomy planned as part of procedure
Other bleeding disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method